Unbound MEDLINE

Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology (Baltimore, Md.) [Hepatology] Journal article

 
TitleToll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.
Author(s)Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA 
InstitutionDepartment of Medicine, University of North Carolina at Chapel Hill, USA.
SourceHepatology 2003 May; 37(5):1043-55.
MeSHAnimals
Antigens, CD14
Blood Proteins
Cells, Cultured
Drosophila Proteins
Hepatocytes
Humans
Intercellular Adhesion Molecule-1
Interleukin-8
JNK Mitogen-Activated Protein Kinases
Lipopolysaccharides
Liver Cirrhosis
Membrane Glycoproteins
Mice
Mice, Inbred C3H
Mitogen-Activated Protein Kinases
Monocyte Chemoattractant Protein-1
NF-kappa B
Receptors, Cell Surface
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Signal Transduction
Toll-Like Receptor 4
Toll-Like Receptors
Transcription Factor AP-1
Up-Regulation
Vascular Cell Adhesion Molecule-1
AbstractBacterial lipopolysaccharide (LPS) stimulates Kupffer cells and participates in the pathogenesis of alcohol-induced liver injury. However, it is unknown whether LPS directly affects hepatic stellate cells (HSCs), the main fibrogenic cell type in the injured liver. This study characterizes LPS-induced signal transduction and proinflammatory gene expression in activated human HSCs. Culture-activated HSCs and HSCs isolated from patients with hepatitis C virus-induced cirrhosis express LPS-associated signaling molecules, including CD14, toll-like receptor (TLR) 4, and MD2. Stimulation of culture-activated HSCs with LPS results in a rapid and marked activation of NF-kappaB, as assessed by in vitro kinase assays for IkappaB kinase (IKK), IkappaBalpha steady-state levels, p65 nuclear translocation, NF-kappaB-dependent luciferase reporter gene assays, and electrophoretic mobility shift assays. Lipid A induces NF-kappaB activation in a similar manner. Both LPS- and lipid A-induced NF-kappaB activation is blocked by preincubation with either anti-TLR4 blocking antibody (HTA125) or Polymyxin B. Lipid A induces NF-kappaB activation in HSCs from TLR4-sufficient (C3H/OuJ) mice but not from TLR4-deficient (C3H/HeJ) mice. LPS also activates c-Jun N-terminal kinase (JNK), as assessed by in vitro kinase assays. LPS up-regulates IL-8 and MCP-1 gene expression and secretion. LPS-induced IL-8 secretion is completely inhibited by the IkappaB super repressor (Ad5IkappaB) and partially inhibited by a specific JNK inhibitor, SP600125. LPS also up-regulates cell surface expression of ICAM-1 and VCAM-1. In conclusion, human activated HSCs utilize components of TLR4 signal transduction cascade to stimulate NF-kappaB and JNK and up-regulate chemokines and adhesion molecules. Thus, HSCs are a potential mediator of LPS-induced liver injury.
Languageeng
Pub Type(s)Journal Article
PubMed ID12717385
  
Advertise on this site.